Cancer

New Technique Uses Microscopic Bubbles to Blast Cancer With Help From GI Research Foundation

With a $500,000 grant from the GI Research Foundation to Dr. Osman Ahmed, UChicago Medicine will be one of only…

12 months ago

Huron Announces 27 Managing Director and Principal Promotions

CHICAGO--(BUSINESS WIRE)--Global professional services firm Huron (NASDAQ: HURN) today announced 27 managing director and principal promotions to recognize these individuals…

12 months ago

Cantargia Reports Phase I Clinical Progress in the CAN10 Project

LUND, SWEDEN / ACCESSWIRE / January 9, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported encouraging progress…

12 months ago

Lynx.MD Expands Gastroenterology Data Repository with Allied Digestive Health Collaboration

Strategic Partnership Reveals Untapped Insights in Gastroenterology Data for Research AdvancementPALO ALTO, CA / ACCESSWIRE / January 9, 2024 /…

12 months ago

Exousia AI Ludwig Enterprises Subsidiary Launches Liposome Research Program

SPARKS, NV / ACCESSWIRE / January 9, 2024 / Ludwig Enterprises, Inc, (OTC:LUDG): A US based biotechnology company with a…

12 months ago

Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA) (“Establishment Labs” or the “Company”), a global medical technology company dedicated to…

12 months ago

eFFECTOR Therapeutics to Host Virtual Investor R&D Day on January 24, 2024

-  Summary of development progress for tomivosertib and zotatifin and a preview of anticipated 2024 milestones- -  Review of recently…

12 months ago

Mainz Biomed Provides Year-End Corporate Review 2023

European Study ColoFuture and U.S. Study eAArly DETECT report sensitivity and specificity for the detection of Colorectal Cancer and Advanced…

12 months ago

Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis

Toronto, Ontario--(Newsfile Corp. - January 9, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a…

12 months ago